Plasmacytoid dendritic cells respond to Epstein-Barr virus infection with a distinct type I interferon subtype profile.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
09 04 2019
Historique:
received: 31 08 2018
accepted: 24 02 2019
entrez: 7 4 2019
pubmed: 7 4 2019
medline: 24 7 2020
Statut: ppublish

Résumé

Infectious mononucleosis, caused by infection with the human gamma-herpesvirus Epstein-Barr virus (EBV), manifests with one of the strongest CD8

Identifiants

pubmed: 30952679
pii: bloodadvances.2018025536
doi: 10.1182/bloodadvances.2018025536
pmc: PMC6457222
doi:

Substances chimiques

Interferon Type I 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1129-1144

Références

Annu Rev Pathol. 2014;9:349-72
pubmed: 24111911
Nat Rev Immunol. 2008 Aug;8(8):594-606
pubmed: 18641647
J Exp Med. 2009 Jun 8;206(6):1423-34
pubmed: 19487422
Annu Rev Genomics Hum Genet. 2013;14:215-43
pubmed: 23724903
PLoS Pathog. 2013;9(5):e1003314
pubmed: 23658517
Eur J Immunol. 1985 May;15(5):520-5
pubmed: 2581792
J Exp Med. 2017 Feb;214(2):269-283
pubmed: 28108590
PLoS Pathog. 2012 Sep;8(9):e1002902
pubmed: 22969425
MAbs. 2018 May/Jun;10(4):651-663
pubmed: 29553870
Cytotechnology. 2014 Jan;66(1):95-105
pubmed: 23404520
Blood. 2013 Feb 28;121(9):1584-94
pubmed: 23297134
PLoS Pathog. 2015 Dec 01;11(12):e1005286
pubmed: 26624012
Genomics. 2004 Aug;84(2):331-45
pubmed: 15233997
Blood. 2002 Dec 15;100(13):4512-20
pubmed: 12393628
Clin Immunol. 2015 Dec;161(2):131-5
pubmed: 26307434
Cytokine. 2011 Jan;53(1):52-9
pubmed: 20943413
Nat Rev Immunol. 2003 Feb;3(2):133-46
pubmed: 12563297
Sci Rep. 2017 Mar 23;7(1):334
pubmed: 28336921
J Virol. 2004 Aug;78(15):8219-28
pubmed: 15254193
Front Immunol. 2014 Oct 30;5:526
pubmed: 25400632
J Virol. 2015 Nov;89(22):11711-4
pubmed: 26339045
Gene Ther. 2002 Oct;9(20):1369-78
pubmed: 12365002
Annu Rev Immunol. 2005;23:275-306
pubmed: 15771572
Annu Rev Immunol. 2011;29:447-91
pubmed: 21219179
PLoS Pathog. 2018 Apr 30;14(4):e1007039
pubmed: 29709016
J Virol. 2016 Jun 10;90(13):6001-6013
pubmed: 27099312
Curr Opin Virol. 2016 Oct;20:71-77
pubmed: 27665065
J Virol. 2002 Jul;76(13):6558-67
pubmed: 12050368
Nat Rev Mol Cell Biol. 2002 Sep;3(9):651-62
pubmed: 12209125
Nat Immunol. 2004 Oct;5(10):987-95
pubmed: 15454922
Nucleic Acids Res. 1985 Feb 11;13(3):791-804
pubmed: 2987810
J Infect Dis. 2015 Dec 15;212(12):1957-61
pubmed: 26080368
Immunol Rev. 2010 Mar;234(1):45-54
pubmed: 20193011
J Clin Invest. 2016 Oct 3;126(10):3772-3782
pubmed: 27571408
Annu Rev Immunol. 2015;33:787-821
pubmed: 25706097
J Immunol. 2010 Sep 15;185(6):3620-31
pubmed: 20713890
Nat Commun. 2018 May 17;9(1):1980
pubmed: 29773792
PLoS Pathog. 2015 Nov 03;11(11):e1005254
pubmed: 26529416
J Exp Med. 2009 Sep 28;206(10):2091-9
pubmed: 19720839
Eur J Immunol. 2013 Jan;43(1):147-58
pubmed: 22996354
J Exp Med. 2003 Dec 1;198(11):1653-63
pubmed: 14657218
J Virol. 2007 Aug;81(15):8016-24
pubmed: 17522215
PLoS Pathog. 2012;8(8):e1002868
pubmed: 22912583
Curr Opin Virol. 2017 Aug;25:113-118
pubmed: 28837889
Nat Rev Cancer. 2016 Dec;16(12):789-802
pubmed: 27687982
Cell Rep. 2013 Dec 26;5(6):1489-98
pubmed: 24360958
Cytokine Growth Factor Rev. 2018 Apr;40:13-18
pubmed: 29475588
Immunity. 2018 Mar 20;48(3):487-499.e5
pubmed: 29525521
J Immunol. 2014 Feb 15;192(4):1982-9
pubmed: 24453245
EMBO J. 2006 Sep 20;25(18):4207-14
pubmed: 16946700
Viral Immunol. 2011 Apr;24(2):159-64
pubmed: 21449726
Curr Top Microbiol Immunol. 2015;390(Pt 1):241-65
pubmed: 26424649
Front Microbiol. 2014 Jun 20;5:308
pubmed: 24999343
Curr Top Microbiol Immunol. 2015;390(Pt 1):151-209
pubmed: 26424647
Curr Opin Virol. 2011 Dec;1(6):487-96
pubmed: 22347990
Sci Rep. 2017 Jan 31;7:41516
pubmed: 28139728
J Immunol. 2009 Jan 15;182(2):851-9
pubmed: 19124728
Blood. 2003 Apr 1;101(7):2727-35
pubmed: 12446459
Blood. 2013 Jun 20;121(25):5034-44
pubmed: 23482932
Annu Rev Immunol. 2012;30:1-22
pubmed: 22136168
Cytokine. 2011 Nov;56(2):282-9
pubmed: 21856167

Auteurs

Cornelia Gujer (C)

Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland.

Anita Murer (A)

Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland.

Anne Müller (A)

Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland.

Danusia Vanoaica (D)

Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland.

Kathrin Sutter (K)

Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Emilie Jacque (E)

LFB Biotechnologies, Lille, France.

Nathalie Fournier (N)

LFB Biotechnologies, Lille, France.

Jens Kalchschmidt (J)

Genomics and Immunity, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD.

Andrea Zbinden (A)

Institute of Medical Virology, University of Zürich, Zürich, Switzerland; and.

Riccarda Capaul (R)

Institute of Medical Virology, University of Zürich, Zürich, Switzerland; and.

Andrzej Dzionek (A)

Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.

Philippe Mondon (P)

LFB Biotechnologies, Lille, France.

Ulf Dittmer (U)

Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Christian Münz (C)

Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH